Singular Genomics offers the G4X platform, an ultra high-throughput spatial sequencing technology that enables integrated multiomic analysis of FFPE samples at subcellular resolution. This platform provides researchers with rapid, scalable insights into RNA, protein, and histological data, facilitating advanced discoveries in genomics and medicine.
Funding
$130.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods for multiomic analysis of FFPE samples often lack the throughput and resolution needed for comprehensive spatial analysis at the subcellular level. This limits the ability to rapidly and cost-effectively process large clinical sample cohorts for translational insights.
Solution
Singular Genomics' G4X platform is an ultra-high-throughput spatial sequencing technology that enables integrated multiomic analysis of FFPE samples at subcellular resolution. The platform combines high-throughput in situ multiomics with next-generation sequencing, allowing researchers to rapidly and scalably analyze RNA, protein, and histological data. The G4X platform facilitates the processing of large retrospective clinical sample cohorts, enabling AI-driven translational insights and accelerating discoveries in genomics and precision medicine.
Target Audience
The primary users are researchers and clinical scientists in translational research, precision diagnostics, and personalized medicine who require high-throughput, high-resolution spatial multiomics data from FFPE samples.
Features
- High-throughput in situ spatial sequencing for multiomic analysis
- Integrated analysis of RNA, protein, and fH&E on the same FFPE tissue section
- Subcellular resolution for single-cell precision
- Rapid processing of up to 20 samples per week
- Compatibility with clinical sample types
- High-performance chemistry and advanced engineering for speed and versatility
- 4 flow cells, 16 lanes for flexible next-generation sequencing